Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Synthetic analogs of thrombospondin and therapeutic use thereof

Synthetic analogs of thrombospondin and therapeutic use thereof

US Patent 6239110 · Granted May 29, 2001

Estimated economic value: $3,700,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Binding proteins and chimeric antigen receptor T cells targeting GASP-1 granules2024
Stabilized peptide fragments from nucleoredoxin X1 and uses thereof2018
Administration of angiocidin for arresting the growth of a tumor cell2016
Serum markers associated with early and other stages of breast cancer2015
G-protein coupled receptor-associated sorting protein 1 as a cancer biomarker2015
Administration of angiocidin for the treatment of leukemia2014
G-protein coupled receptor-associated sorting protein 1 as a cancer biomarker2013
Method for detecting disease markers2012
Methods and compositions for inhibiting angiogenesis2009
Methods and compositions for inhibiting angiogenesis2007
Compositions for treating chemotherapy-resistant tumor cells and targeted chemot2002
Retroinverso polypeptides that mimic or inhibit thrombospondin activity2002